key: cord-0303731-9lp20xoj authors: Vengesai, Arthur; Kasambala, Maritha; Mutandadzi, Hamlet; Mduluza-Jokonya, Tariro L.; Mduluza, Takafira; Naicker, Thajasvarie title: Scoping review of the applications of peptide microarrays on the fight against human infections date: 2021-03-04 journal: bioRxiv DOI: 10.1101/2021.03.04.433859 sha: 60d27471dfa044f78c87719ce1a74a477c272e8d doc_id: 303731 cord_uid: 9lp20xoj Introduction This scoping review explores the use of peptide microarrays in the fight against infectious diseases. The research domains explored included the use of peptide microarrays in the mapping of linear B-cell and T cell epitopes, antimicrobial peptide discovery, immunosignature characterisation and disease immunodiagnostics. This review also provides a short overview of peptide microarray synthesis. Methods Electronic databases were systematically searched to identify relevant studies. The review was conducted using the Joanna Briggs Institute methodology for scoping reviews and data charting was performed using a predefined form. The results were reported by narrative synthesis in line with the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews guidelines. Results Eighty-six articles from 100 studies were included in the final data charting process. The majority (93%) of the articles were published during 2010–2020 and were mostly from Europe (44%) and North America (34 %). The findings were from the investigation of viral (44%), bacterial (30%), parasitic (25%) and fungal (2%) infections. Out of the serological studies, IgG was the most reported antibody type followed by IgM. The largest portion of the studies (78%) were related to mapping B-cell linear epitopes, 10% were on diagnostics, 9% reported on immunosignature characterisation and 6% reported on viral and bacterial cell binding assays. Two studies reported on T-cell epitope profiling. Conclusion The most important application of peptide microarrays was found to be B-cell epitope mapping or antibody profiling to identify diagnostic and vaccine targets. Immunosignatures identified by random peptide microarrays were found to be applied in the diagnosis of infections and interrogation of vaccine responses. The analysis of the interactions of random peptide microarrays with bacterial and viral cells using binding assays enabled the identification of antimicrobial peptides. Peptide microarray arrays were also used for T-cell linear epitope mapping which may provide more information for the design of peptide-based vaccines and for the development of diagnostic reagents. Infectious diseases also known as communicable diseases are a major growing concern Search strategy information sources and search terms 144 The following online data bases PubMed, Medline complete, The Cochrane Central Register 145 of Controlled Trials (CENTRAL) and Web of Science were systematically searched from 146 their inception without any restrictions on language or date of publication. The data bases 147 were searched using predefined keywords. Table 1 illustrates the search terms and strategy 148 for PubMed which was adapted for the other databases. Additionally grey literature databases 149 GreyLit and OpenGrey were searched and a manual search of the reference lists of relevant 150 publications and reviews was conducted. Review process and data charting 156 The retrieved literature were downloaded into Mendeley reference manager, and duplicates 157 were removed. One reviewer (AV) assessed the titles of the studies identified by the search 158 and excluded irrelevant studies. Two reviewers (AV and MK) independently assessed the 159 eligibility of the abstracts and full texts of the retrieved studies to avoid bias. After the 160 articles were selected, data was extracted and recorded in the excel spreadsheet. One author 161 (AV) extracted and recorded the data from each study according to a pretested data extraction 162 excel spreadsheet form (additional file 1) and a second reviewer (HM or MK or TMJ) 163 verified the extracted data. Discrepancies were resolved by consensus and a third evaluator. 164 The extracted data were author, date of publication, DOI, Aim and study domain, 165 geographical location, microorganism or infection, antibody type, epitope 166 prediction/selection, peptide synthesis, microarray printing and key findings. Peptide microarrays displayed short peptides (ranging 10-20 amino acid residues). Of note, mapping T-cell epitopes. Antibodies recognize and bind their target protein antigens via surface accessible interaction 307 sites, the linear epitopes or the conformational epitopes (38). High-content peptide 308 microarrays allow linear epitope profiling of entire pathogen proteomes (42) . There is great Whole CMV proteome pattern recognition analysis after HSCT identifies unique 603 epitope targets associated with the CMV status Towards high-throughput immunomics for infectious diseases: Use of next-generation 608 peptide microarrays for rapid discovery and mapping of antigenic determinants Humoral immune profiling of mycobacterial antigen recognition in sarcoidosis and 613 Löfgren's syndrome using high-content peptide microarrays Mapping of the 616 antigenic regions of streptokinase in humans after streptokinase therapy Screening of bacteria-620 binding peptides and one-pot ZnO surface modification for bacterial cell entrapment Structure-activity relationship study using 623 peptide arrays to optimize Api137 for an increased antimicrobial activity against 624 Pseudomonas aeruginosa Identification of novel antibacterial peptides by chemoinformatics and machine 629 learning Screening and optimizing 631 antimicrobial peptides by using SPOT-synthesis High-throughput platform for rapid deployment of 635 antimicrobial agents Bacterial glycoprofiling by using random sequence peptide 638 microarrays A 641 Simple Platform for the Rapid Development of Antimicrobials. Sci Rep Application of 644 synthetic peptide arrays to uncover cyclic di-GMP binding motifs Scalable 647 high-density peptide arrays for comprehensive health monitoring A general method for 650 characterization of humoral immunity induced by a vaccine or infection. Vaccine 651 Application of immunosignatures for diagnosis of valley fever Humoral 658 immunity profiling of subjects with myalgic encephalomyelitis using a random peptide 659 microarray differentiates cases from controls with high specificity and sensitivity Serology 663 in the Digital Age: Using Long Synthetic Peptides Created from Nucleic Acid 664 Sequences as Antigens in Microarrays. Microarrays Serotyping of Toxoplasma gondii Infection Using Peptide Membrane Arrays. Front 667 Computational analysis of dengue virus envelope protein (E) reveals an epitope 671 with flavivirus immunodiagnostic potential in peptide microarrays A novel 675 synthetic peptide microarray assay detects Chlamydia species-specific antibodies in 676 animal and human sera Throughput Identification of MHC Class I Binding Peptides Using an Ultradense 680 High-density peptide arrays for malaria vaccine 682 development Design and application of GB virus C 686 (GBV-C) peptide microarrays for diagnosis of GBV-C/HIV-1 co-infection The distribution and functions of immunoglobulin isotypes -Immunobiology -NCBI Bookshelf High-throughput platform for rapid deployment of 693 antimicrobial agents PRISMA Extension for Scoping Reviews guidelines checklist General characteristics of the studies included in the scoping review The authors would like to acknowledge the valuable input of Professor Francisca Mutapi.